Alliance Pharma shares slide following challenging H1
20th Jul 2022 10:07
(Sharecast News) - Healthcare outfit Alliance Pharma reiterated full-year guidance on Wednesday as it said challenges faced in the first half were expected to ease in the second.
Read moreAlliance Pharma in 'good health' amid strong demand
18th May 2022 14:47
(Sharecast News) - Alliance Pharma said in an update on Wednesday that its business was in "good health", with demand for its brand strong.
Read moreAlliance Pharma upbeat on prospects for US acquisitions
25th Mar 2022 11:31
(Sharecast News) - Alliance Pharma completed the acquisition of both 'ScarAway' - the largest silicone-based scar treatment brand in the US - and the rights to sell 'Kelo-cote' in the American retail consumer market in the US on Friday.
Read moreAlliance Pharma reports 'strong' 2021 performance
22nd Mar 2022 12:16
(Sharecast News) - Alliance Pharma reported a "strong" operational and financial performance in its 2021 results on Tuesday, with underlying revenue up 23% on a see-through basis to £169.6m.
Read moreCMA issues £35m in fines for illegal anti-nausea tablet supply arrangement
3rd Feb 2022 08:29
(Sharecast News) - The Competition and Markets Authority has fined several pharmaceutical and private equity firms over £35.0m for an illegal arrangement in the supply of important NHS prescription anti-nausea tablets.
Read moreAlliance Pharma set to top underlying profit expectations
18th Jan 2022 13:06
(Sharecast News) - Alliance Pharma reported "strong" full-year growth in a trading update on Tuesday, with see-through revenue rising 23%, or 27% on a constant currency basis, to £169.6m.
Read moreAlliance Pharma trades strongly in first half
21st Sep 2021 11:10
(Sharecast News) - Healthcare company Alliance Pharma reported strong trading in its first half on Tuesday, reporting a 24% rise in see-through revenue to £80.9m.
Read moreAlliance Pharma trades strongly through first half
20th Jul 2021 09:44
(Sharecast News) - Healthcare company Alliance Pharma updated the market on its first half on Tuesday, reporting that it had traded "strongly", with see-through revenue rising 24% year-on-year to £80.9m, or 28% on a constant currency basis.
Read moreStrong trading continues in new year for Alliance Pharma
19th May 2021 09:00
(Sharecast News) - Alliance Pharma updated the market on its trading on Wednesday, reiterating that the year had started well, adding that it was continuing to see some "strong performances" from its key brands.
Read moreConsumer brands underpin Alliance Pharma performance
23rd Mar 2021 11:01
(Sharecast News) - Alliance Pharma reported a 4% fall in statutory revenue in its preliminary results on Tuesday, to £129.8m, although it said performance from its consumer healthcare brands was "strong", with that division now accounting for more than two thirds of group see-through revenues.
Read moreAlliance Pharma revenues hit by Covid-19 in H1
21st Jul 2020 10:24
(Sharecast News) - Healthcare group Alliance Pharma said on Tuesday that first-half revenues had been impacted by the Covid-19 pandemic, principally in its prescription medicines business.
Read moreAlliance Pharma lowers net debt after "strong" revenue growth in 2019
22nd Jan 2020 11:32
(Sharecast News) - International healthcare group Alliance Pharma said it had recorded some strong revenue growth in 2019 on Wednesday as well as a rapid reduction in net debt.
Read moreAlliance Pharma handing back 'Xonvea' rights to Duchesnay
27th Nov 2019 15:00
(Sharecast News) - Alliance Pharma has reached agreement with Duchesnay of Canada to return the UK and EU licensing rights to 'Xonvea', a prescription medicine for the treatment of nausea and vomiting of pregnancy where conservative management has failed, it announced on Wednesday.
Read moreAlliance Pharma's 'Xonvea' gets approval in Ireland
10th Apr 2019 16:05
(Sharecast News) - Alliance Pharma announced on Wednesday that 'Xonvea' has gained marketing approval in the Republic of Ireland from the country's medicines regulator, the Health Products Regulatory Authority, for the treatment of nausea and vomiting of pregnancy where conservative management has failed.
Read moreAlliance Pharma's revenues climb as 'star' products shine
21st Jan 2019 12:42
(Sharecast News) - Alliance Pharma on Monday reported a jump in revenue after a strong performance from its 'star' products and newly acquired Nizoral brand.
Read more